Company intelligence / Profile preview

CARR Separations

Clearwater, Florida, United States

Ownership: Private
Development stage: Other

Overview

CARR Separations is a premier provider of centrifugal separation systems tailored for the biotechnology and pharmaceutical manufacturing sectors. The company specializes in high-performance liquid-solid separation technology, offering products such as the Powerfuge, Viafuge, and the innovative single-use UniFuge system. These systems are designed to handle shear-sensitive cells and are extensively used in the production of vaccines, monoclonal antibodies, and cell-based therapies. Currently operating as a brand under PneumaticScaleAngelus, a Barry-Wehmiller company, CARR Separations continues to lead in bioprocessing efficiency and scalability for both clinical and commercial manufacturing.

Modalities: Monoclonal antibodyVaccineCell therapyBiologicGene therapy
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on CARR Separations.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CARR Separations.

Explore the full profile